| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 [G. N. F., J. E. U., J. M. M., M. D. W., Y. J. H., P. E. N., S. J. C.]; Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland 20892 [C. F. Q., D. I. L., E. M. P., H. C. M., V. V. L.]; Department of Biological Sciences, University of Essex, Essex CO4 3SQ, United Kingdom [E. M. K.]; Cross Cancer Institute, Edmonton, Alberta, T6G 1Z2 Canada [P. E. G.]; Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 [A. P. F.]; Department of Pathology, University of Leiden, NL-2300 RA Leiden, the Netherlands [A-M. C-J., E. W. M., C. J. C.]; Department of Urology, School of Medicine, Chiba University, Chiba 260, Japan [H. S., A. K.]; Department of Clinical Genetics, Karolinska Hospital, 510401 Stockholm, Sweden [A. L.]; and Laboratoire de Génétique Moléculaire, Institut Bergonié, 33076 Bordeaux, France [F. D-B.]
CTCF is a widely expressed 11-zinc finger (ZF) transcription factor that is involved in different aspects of gene regulation including promoter activation or repression, hormone-responsive gene silencing, methylation-dependent chromatin insulation, and genomic imprinting. Because CTCF targets include oncogenes and tumor suppressor genes, we screened over 100 human tumor samples for mutations that might disrupt CTCF activity. We did not observe any CTCF mutations leading to truncations/premature stops. Rather, in breast, prostate, and Wilms tumors, we observed four different CTCF somatic missense mutations involving amino acids within the ZF domain. Each ZF mutation abrogated CTCF binding to a subset of target sites within the promoters/insulators of certain genes involved in regulating cell proliferation but did not alter binding to the regulatory sequences of other genes. These observations suggest that CTCF may represent a novel tumor suppressor gene that displays tumor-specific "change of function" rather than complete "loss of function."
This article has been cited by other articles:
![]() |
I. A. De La Rosa-Velazquez, H. Rincon-Arano, L. Benitez-Bribiesca, and F. Recillas-Targa Epigenetic Regulation of the Human Retinoblastoma Tumor Suppressor Gene Promoter by CTCF Cancer Res., March 15, 2007; 67(6): 2577 - 2585. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Hancock, K. W. Brown, K. Moorwood, H. Moon, C. Holmgren, S. H. Mardikar, A. R. Dallosso, E. Klenova, D. Loukinov, R. Ohlsson, et al. A CTCF-binding silencer regulates the imprinted genes AWT1 and WT1-AS and exhibits sequential epigenetic defects during Wilms' tumourigenesis Hum. Mol. Genet., February 1, 2007; 16(3): 343 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ghochikyan, M. Mkrtichyan, D. Loukinov, G. Mamikonyan, S. D. Pack, N. Movsesyan, T. E. Ichim, D. H. Cribbs, V. V. Lobanenkov, and M. G. Agadjanyan Elicitation of T Cell Responses to Histologically Unrelated Tumors by Immunization with the Novel Cancer-Testis Antigen, Brother of the Regulator of Imprinted Sites J. Immunol., January 1, 2007; 178(1): 566 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kim, D. Li, Y. Cui, K. Mueller, W. C. Chears, and J. DeJong Regulatory Factor Interactions and Somatic Silencing of the Germ Cell-specific ALF Gene J. Biol. Chem., November 10, 2006; 281(45): 34288 - 34298. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Hong, Y. Kang, Z. Abdullaev, P. T. Flanagan, S. D. Pack, M. R. Fischette, M. T. Adnani, D. I. Loukinov, S. Vatolin, J. I. Risinger, et al. Reciprocal Binding of CTCF and BORIS to the NY-ESO-1 Promoter Coincides with Derepression of this Cancer-Testis Gene in Lung Cancer Cells Cancer Res., September 1, 2005; 65(17): 7763 - 7774. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Torrano, I. Chernukhin, F. Docquier, V. D'Arcy, J. Leon, E. Klenova, and M. D. Delgado CTCF Regulates Growth and Erythroid Differentiation of Human Myeloid Leukemia Cells J. Biol. Chem., July 29, 2005; 280(30): 28152 - 28161. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Docquier, D. Farrar, V. D'Arcy, I. Chernukhin, A. F. Robinson, D. Loukinov, S. Vatolin, S. Pack, A. Mackay, R. A. Harris, et al. Heightened Expression of CTCF in Breast Cancer Cells Is Associated with Resistance to Apoptosis Cancer Res., June 15, 2005; 65(12): 5112 - 5122. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. E. Garrett, A. V. Emelyanov, M. A. Sepulveda, P. Flanagan, S. Volpi, F. Li, D. Loukinov, L. A. Eckhardt, V. V. Lobanenkov, and B. K. Birshtein Chromatin Architecture near a Potential 3' End of the Igh Locus Involves Modular Regulation of Histone Modifications during B-Cell Development and In Vivo Occupancy at CTCF Sites Mol. Cell. Biol., February 15, 2005; 25(4): 1511 - 1525. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Wei, T. Miura, P. Robson, S.-K. Lim, X.-Q. Xu, M. Y.-C. Lee, S. Gupta, L. Stanton, Y. Luo, J. Schmitt, et al. Transcriptome Profiling of Human and Murine ESCs Identifies Divergent Paths Required to Maintain the Stem Cell State Stem Cells, February 1, 2005; 23(2): 166 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Tam, T. R. Devereux, A. C. Patel, J. F. Foley, R. R. Maronpot, and T. E. Massey Perturbations of the Ink4a/Arf gene locus in aflatoxin B1-induced mouse lung tumors Carcinogenesis, January 1, 2003; 24(1): 121 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kanduri, M. Kanduri, L. Liu, N. Thakur, S. Pfeifer, and R. Ohlsson The Kinetics of Deregulation of Expression by de Novo Methylation of the H19 Imprinting Control Region in Cancer Cells Cancer Res., August 15, 2002; 62(16): 4545 - 4548. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. I. Loukinov, E. Pugacheva, S. Vatolin, S. D. Pack, H. Moon, I. Chernukhin, P. Mannan, E. Larsson, C. Kanduri, A. A. Vostrov, et al. BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma PNAS, May 14, 2002; 99(10): 6806 - 6811. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |